Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer

By Miyake Kotaro   Shimada Mitsuo   Nishioka Masanori   Sugimoto Koji   Batmunkh Erdenebulgan   Uto Yoshihiro   Nagasawa Hideko   Hori Hitoshi  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 885-892

Springer Publishing Company

Access to resources Recommend Favorite

Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 637-645

Spandidos Publications

Access to resources Recommend Favorite

Disregulation of Urokinase Plasminogen Activator Gene in Breast Cancer

By Hubbard A.L.   Lauder J.   Hawkins R.A.   Anderson T.J.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases – A comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases

By Fisher J.L.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 1, 2000-05 ,pp. : 1-12

Springer Publishing Company

Access to resources Recommend Favorite